In addition, the serum FSH level was significantly different in comparisons between the all-COVID-19 group and healthy control (6.35 vs. 7.81 mIU/ml, P = 0.02); Despite no difference with basal level (P = 0.403), still more COVID-19 women had a relatively higher FSH (FSH ≥ 10 mIU/ml: 53.80 vs. 34.7%, P = 0.041) than in the basal level group. The gene discussed is BRD2; the disease is COVID-19.